TABLE 1.
Construct | ORF50 aa | Point mutant(s) | Abundant ORF50 proteina | DNA bindingb | Figure(s) |
---|---|---|---|---|---|
F-ORF50/F-691 | 1-691 | No | No | No | 1, 2 |
F-ORF50/F-691 (KK/EE) | 1-691 | K527E, K528E | Yes | Yes | 1, 2 |
F-ORF50(KK/AA) | 1-691 | K527A, K528A | Yes | Yes | 1 |
F-ORF50(KK/RR) | 1-691 | K527R, K528R | Yes | No | 1 |
F-650 | 1-650 | No | No | No | 2 |
F-650(KK/EE) | 1-650 | K527E, K528E | Yes | Yes | 2 |
F-590 | 1-590 | No | Yes* | No | 2 |
F-590(KK/EE) | 1-590 | K527E, K528E | Yes* | Yes | 2 |
F-564 | 1-564 | No | Yes* | Trace | 2, 4, 5 |
F-564(KK/EE) | 1-564 | K527E, K528E | Yes* | Yes | 2, 4, 5 |
F-490 | 1-490 | No | Yes* | (Yes) | 2 |
F-D590-650 | 1-589; 651-691 | No | Yes* | No | 2 |
F-D590-650(KK/EE) | 1-589; 651-691 | K527E, K528E | Yes* | Yes | 2 |
F-390 | 1-390 | No | Yes* | Yes | 4 |
F-390+(440-564) | 1-390; 440-564 | No | (Yes*)c | (No) | 4 |
F-390+(440-564)(KK/EE) | 1-390; 440-564 | K527E, K528E | (Yes*) | (Yes) | 4 |
F-390+(490-564) | 1-390; 440-564 | No | Yes* | Weak | 4 |
F-390+(490-564)(KK/EE) | 1-390; 490-564 | K527E, K528E | Yes* | Yes | 4 |
F-390+(520-564) | 1-390; 520-564 | No | Yes* | Yes | 4 |
F-390+(520-564)(KK/EE) | 1-390; 520-564 | K527E, K528E | Yes* | Yes | 4 |
F-390+(535-564) | 1-390; 535-564 | No | Yes* | Yes | 4 |
F-390+(490-535) | 1-390; 490-535 | No | Yes* | Weak | 4 |
F-390+(490-535)(KK/EE) | 1-390; 490-535 | K527E, K528E | Yes* | Yes | 4 |
F-564(KRK/EDE) | 1-564 | K516E, R517D, K518E | Yes* | Yes | 5 |
F-564(RSK/DSE) | 1-564 | R520D, K522E | Yes* | Yes | 5 |
F-ORF50(KRK/EDE) | 1-691 | K516E, R517D, K518E | No | Yes | 5 |
F-ORF50(RSK/DSE) | 1-691 | R520D, K522E | No | Yes | 5 |
F-564(KK/EE)+IS | 1-564; 490-535 | K527E, K528E | Yes* | No | 6 |
F-564(KK/EE)+IS(KK/EE) | 1-564; 490-535 | K527E, K528E (2×)d | Yes* | Yes | 6 |
F-IS + 564(KK/EE) | 490-535; 1-564 | K527E, K528E | Yes* | Weak | 6 |
F-IS(KK/EE)+564(KK/EE) | 490-535; 1-564 | K527E, K528E (2×) | Yes* | Yes | 6 |
F-ORF50(KK/EE)+IS | 1-691; 490-435 | K527E, K528E | No | No | 8 |
F-ORF50(KK/EE)+IS-E | 1-691; 490-435 | K527E, K528E (2×) | Yes | Yes | 8 |
F-ORF50(KK/EE)+KK9 | 1-691; 525-533 | K527E, K528E | No | Yes | 8 |
F-ORF50(KK/EE)+EE9 | 1-691; 525-533 | K527E, K528E (2×) | Yes | Yes | 8 |
F-ORF50(KK/EE)+KKRK | 1-691; 527-530 | K527E, K528E | Yes | Yes | 8 |
F-ORF50(KK/EE)+EERK | 1-691; 527-530 | K527E, K528E (2×) | Yes | Yes | 8 |
F-N-IS-ORF50(KK/EE) | 490-535; 1-691 | K527E, K528E | No | Weak | 9 |
F-N-IS(KK/EE)-ORF50(KK/EE) | 490-535; 1-691 | K527E, K528E (2×) | Yes | Yes | 9 |
F-PARS | 1-20; 490-691 | No | Yes* | NAe | 10 |
F-PARS(KK/EE) | 1-20; 490-691 | K527E, K528E | Yes* | NA | 10 |
*, We were unable to determine whether the abundant form of ORF50 expressed by truncation mutants was ORF50A or ORF50B.
“(Yes)” and “(No)” data for DNA binding are not shown in this study.
“(Yes*)” data for protein abundance are not shown in this study.
2×, Two occurrences.
NA, not applicable.